The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats

被引:26
|
作者
Khayyal M.T. [2 ]
El-Ghazaly M.A. [1 ]
El-Hazek R.M. [1 ]
Nada A.S. [1 ]
机构
[1] Drug Radiation Research Department, National Centre for Radiation Research and Technology, Atomic Energy Authority, Cairo
[2] Pharmacology Department, Faculty of Pharmacy, Cairo University, Cairo
关键词
Acute inflammation; Celecoxib; Cyclooxygenase; Cytokines; Diclofenac; Prostanoids; Reactive oxygen species;
D O I
10.1007/s10787-009-0014-z
中图分类号
学科分类号
摘要
The potential value of selective and non-selective COX-2 inhibitors in preventing some of the biochemical changes induced by ionizing radiation was studied in rats exposed to carrageenan-induced paw edema and 6-day-old air pouch models. The animals were exposed to different exposure levels of γ-radiation, namely either to single doses of 2 and 7.5 Gy or a fractionated dose level of 7.5 Gy delivered as 0.5 Gy twice weekly for 7.5 weeks. The inflammatory response produced by carrageenan in irradiated rats was markedly higher than that induced in non-irradiated animals, and depended on the extent of irradiation. Celecoxib, a selective COX-2 inhibitor, in doses of 3, 5, 10, and 15 mg/kg was effective in reducing paw edema in irradiated and non-irradiated rats in a dose-dependent manner as well as diclofenac (3 mg/kg), a non-selective COX inhibitor. Irradiation of animals before the induction of the air pouch by an acute dose of 2 Gy led to a significant increase in leukocytic count, as well as in the level of interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), LTB4, PGE2 (as an index of COX-2 activity), TXB 2 (as an index of COX-1 activity), and the plasma level of MDA. This increase in level of these parameters was more marked than that observed in the non-irradiated animals subjected to the inflammagen. The blood GSH level was not affected by the dose of irradiation used, whereas superoxide dismutase (SOD) activity was suppressed. In many respects, celecoxib (5 mg/kg) was as potent as diclofenac in decreasing the elevated levels of IL-6, IL-1β, TNF-α, LTB4, PGE2, but lacked any significant effect on TXB 2 level. Since it is mostly selective for COX-2 with a rare effect on COX-1 enzyme, both drugs at the selected dose levels showed no effect on level of MDA, GSH, and SOD activity. © 2009 Birkhäuser Verlag, Basel/Switzerland.
引用
收藏
页码:255 / 266
页数:11
相关论文
共 50 条
  • [41] Celecoxib, a selective COX-2 inhibitor, reduces diabetes-induced retinal VEGF expression both in vitro and in vivo
    Ayalasomayajula, SP
    Kompella, UB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U298 - U298
  • [43] Isolation, synthesis and characterization of impurities in Celecoxib a cox-2 inhibitor
    Satyanarayana, U
    Rao, DS
    Kumar, YR
    Babu, JM
    Kumar, PR
    Reddy, JT
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (04) : 951 - 957
  • [44] Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib
    Nishimura, N
    Urade, M
    Hashitani, S
    Noguchi, K
    Manno, Y
    Takaoka, K
    Sakurai, K
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2004, 33 (10) : 614 - 621
  • [45] COX-2 Inhibitor, Celecoxib, May Prevent Lung Cancer
    不详
    ONCOLOGY-NEW YORK, 2011, 25 (09): : 848 - 849
  • [46] A Study of the cytotoxic effects of cetuximab and the interaction with a selective Cox-2 inhibitor (Celecoxib) in breast cancer cell lines.
    Halaweh, Osama
    Yakan, Adli
    Lobocki, Catherine L.
    Drelichman, Anibal
    CANCER RESEARCH, 2006, 66 (08)
  • [47] Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
    Bocca, Claudia
    Bozzo, Francesca
    Bassignana, Andrea
    Miglietta, Antonella
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 350 (1-2) : 59 - 70
  • [48] Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats
    Takeda, J
    Kitajima, K
    Fujii, S
    Horiuchi, H
    Hori, H
    Chibana, Y
    Okuyama, T
    Tominaga, K
    Ichikawa, K
    Ono, Y
    Teramoto, T
    Ohkura, Y
    Imura, J
    Shinoda, M
    Chiba, T
    Sakamoto, C
    Kawamata, H
    Fujimori, T
    ONCOLOGY REPORTS, 2004, 11 (05) : 981 - 985
  • [49] Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor
    Saito, T
    Rodger, I
    Shennib, H
    Hu, F
    Tayara, L
    Giaid, A
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 114 - 119
  • [50] Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
    Claudia Bocca
    Francesca Bozzo
    Andrea Bassignana
    Antonella Miglietta
    Molecular and Cellular Biochemistry, 2011, 350 : 59 - 70